CRP and Cognitive impairment: Consistently, results of clinical studies have demonstrated an increased serum level of IL-6 and C-reactive protein (CRP) in T2DM patients with cognitive impairment, and some inflammatory factors were suggested to be taken as potential biomarkers for predicting T2DM-related dementia and cognitive impairment [14].